Litcius/Paper detail

Helicobacter pylori infection induces STAT3 phosphorylation on Ser727 and autophagy in human gastric epithelial cells and mouse stomach

Juan‐Yu Piao, Su‐Jung Kim, Do-Hee Kim, Ji Hyun Park, Sin‐Aye Park, Hyeong-jun Han, Hye-Kyung Na, Kichul Yoon, Ha-Na Lee, Nayoung Kim, Ki Baik Hahm, Young‐Joon Surh

2020Scientific Reports41 citationsDOIOpen Access PDF

Abstract

Abstract Helicobacter pylori ( H. pylori ) infection is considered as one of the principal risk factors of gastric cancer. Constitutive activation of the signal transducer and activator of transcription 3 (STAT3) plays an important role in inflammation-associated gastric carcinogenesis. In the canonical STAT3 pathway, phosphorylation of STAT3 on Tyr705 is a major event of STAT3 activation. However, recent studies have demonstrated that STAT3 phosphorylated on Ser727 has an independent function in mitochondria. In the present study, we found that human gastric epithelial AGS cells infected with H. pylori resulted in localization of STAT3 phosphorylated on Ser727 (P-STAT3 Ser727 ), predominantly in the mitochondria. Notably, H. pylori -infected AGS cells exhibited the loss of mitochondrial integrity and increased expression of the microtubule-associated protein light chain 3 (LC3), the autophagosomal membrane-associated protein. Treatment of AGS cells with a mitophagy inducer, carbonyl cyanide 3-chlorophenylhydrazone (CCCP), resulted in accumulation of P-STAT3 Ser727 in mitochondria. In addition, the elevated expression and mitochondrial localization of LC3 induced by H. pylori infection were attenuated in AGS cells harboring STAT3 mutation defective in Ser727 phosphorylation (S727A). We also observed that both P-STAT3 Ser727 expression and LC3 accumulation were increased in the mitochondria of H. pylori -inoculated mouse stomach.

Topics & Concepts

STAT3Helicobacter pyloriPhosphorylationMitochondrionAutophagyCancer researchChemistryBiologyCell biologyApoptosisBiochemistryGeneticsHelicobacter pylori-related gastroenterology studiesCytokine Signaling Pathways and InteractionsIL-33, ST2, and ILC Pathways